Indication
Treatment of unresectable or metastatic melanoma. Treatment of unresectable melanoma, with NRA Q61 mutation.
Loading your page…
Loading your page…
Melanoma
Marketing Authorisation Holder: Pierre Fabre Médicament
INN: binimetinib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Balimek: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.